吸入麻醉与全凭静脉麻醉对消化道肿瘤手术患者预后的影响

2020
10/14

+
分享
评论
米勒之声
A-
A+

在接受消化道手术的患者中,吸入麻醉和全凭静脉麻醉的总体生存率和无癌复发生存率相似,此类患者麻醉方式的选择应基于其他因素。


本文由“罂粟花”授权转载

吸入麻醉全凭静脉麻醉对消化肿瘤手术患者预后的影响

翻译:吴学艳  编辑:冯玉蓉  审校:曹莹


背景:以往的实验临床研究表明不同麻醉剂对癌症患者手术预后影响不同,但这些研究结果并不一致本研究接受吸入麻醉或全凭静脉麻醉的消化道肿瘤手术患者的总体生存率和无复发生存率进行了比较


方法:作者使用日本诊断程序组合数据库选择了从20107月至20183期间接受择期食管切除术、胃切除术、肝切除术、胆囊切除术、胰腺切除术、结肠切除术直肠癌手术患者患者分为吸入麻醉组(地氟醚、七氟醚或异氟醚加/不加氧化二氮)和丙泊酚全凭静脉麻醉组假设全凭静脉麻醉比吸入麻醉具有更高的总体生存率和无复发生存率每种手术类型进行亚组分析。


结果:纳入196303名符合条件患者(吸入麻醉166,966丙泊酚静脉麻醉组29,337)吸入麻醉组和全凭静脉麻醉组死亡人数(比例)分别为17319(10.4%)3339(11.4%)。两组总生存率(风险比 1.0295%CI 0.98~1.07P=0.28)或无复发生存率(风险比 0.9995%CI 0.96~1.03P=0.59)无显著性差异,而工具变量分析显示,两组无复发生存率略有差异(风险比 0.9295%CI 0.87~0.98P=0.01)。亚组分析显示,在任何类型的手术中,各组之间的总体或无复发生存率没有显著差异。


结论:在接受消化道手术的患者中,吸入麻醉全凭静脉麻醉的总体生存率和无复发生存率相似此类患者麻醉方式选择基于其他因素


原始文献来源 Makito K,  Matsui H,  Fushimi K, et al.Volatile versus Total Intravenous Anesthesia for Cancer Prognosis in Patients Having Digestive Cancer Surgery.[J].Anesthesiology 2020 Oct 01;1334(4) .



Volatile versus Total Intravenous Anesthesia for Cancer Prognosis in Patients Having Digestive Cancer Surgery

ABSTRACT

Background: Previous experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were inconsistent among these studies. The authors compared overall and recurrence-free survival in patients given volatile or intravenous anesthesia for digestive tract cancer surgery.


Methods: The authors selected patients who had elective esophagectomy, gastrectomy, hepatectomy, cholecystectomy, pancreatectomy, colectomy, and rectal cancer surgery from July 2010 to March 2018 using the Japanese Diagnosis Procedure Combination database. Patients were divided into a volatile anesthesia group (desflurane, sevoflurane, or isoflurane with/without nitrous oxide) and a propofol-based total intravenous anesthesia group. The authors hypothesized that total intravenous anesthesia is associated with greater overall and recurrence-free survival than volatile anesthesia. Subgroup analyses were performed for each type of surgery.


Results: The authors identified 196,303 eligible patients (166,966 patients in the volatile anesthesia group and 29,337 patients in the propofol-based total intravenous anesthesia group). The numbers (proportions) of death in the volatile anesthesia and total intravenous anesthesia groups were 17,319 (10.4%) and 3,339 (11.4%), respectively. There were no significant differences between the two groups in overall survival (hazard ratio, 1.02; 95% CI, 0.98 to 1.07; P = 0.28) or recurrence-free survival (hazard ratio, 0.99; 95% CI, 0.96 to 1.03; P = 0.59), whereas instrumental variable analyses showed a slight difference in recurrence-free survival (hazard ratio, 0.92; 95% CI, 0.87 to 0.98; P = 0.01). Subgroup analyses showed no significant difference in overall or recurrence-free survival between the groups in any type of surgery.


Conclusions: Overall and recurrence-free survival were similar between volatile and intravenous anesthesia in patients having digestive tract surgery. Selection of the anesthetic approach for these patients should be based on other factors.




  

免责声明:

本微信公众平台所刊载原创或转载内容不代表米勒之声的观点或立场。文中所涉及药物使用、疾病诊疗等内容仅供参考。


本文由作者自行上传,并且作者对本文图文涉及知识产权负全部责任。如有侵权请及时联系(邮箱:guikequan@hmkx.cn
关键词:
消化道,切除术,麻醉,静脉

人点赞

收藏

人收藏

打赏

打赏

我有话说

0条评论

0/500

评论字数超出限制

表情
评论

为你推荐

推荐课程


社群

精彩视频

您的申请提交成功

确定 取消
剩余5
×

打赏金额

认可我就打赏我~

1元 5元 10元 20元 50元 其它

打赏

打赏作者

认可我就打赏我~

×

扫描二维码

立即打赏给Ta吧!

温馨提示:仅支持微信支付!